Fixed combination of glycopyrrolate and formoterol MDI (GFF-MDI) demonstrates superior inspiratory capacity (IC) compared to tiotropium DPI (Tio) following 7 days dosing, in a randomized, double-blind, placebo-controlled phase 2b study in patients with COPD
Colin Reisner, Earl St. Rose, Shannon Strom, Tracy Fischer, Michael Golden, Mervyn Thomas, Chadwick Orevillo
European Respiratory Journal 2011 38: p879; DOI: